TG Therapeutics Stock Options Expiring on 21st of February

TGTX Stock  USD 29.55  0.41  1.41%   
TG Therapeutics' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.97 with a put-to-call open interest ratio of 0.35 over 83 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on February 21st 2025. The total put volume is at 245, with calls trading at the volume of 3.5 K. This yields a 0.07 put-to-call volume ratio.

Open Interest Against February 21st 2025 Option Contracts

TG Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in TG Therapeutics' lending market. For example, when TG Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on TG Therapeutics, he or she must hedge the risk by shorting TG Therapeutics stock over its option's life.
The chart above shows TG Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. TG Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for TG Therapeutics' option, there is no secondary market available for investors to trade.

TG Therapeutics Maximum Pain Price Across 2025-02-21 Option Contracts

Max pain occurs when TG Therapeutics' market makers reach a net positive position across all TG Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, TG Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

TG Therapeutics In The Money Call Balance

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying TG Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on TG Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

TGTX Current Options Market Mood

TG Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps TGTX Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most TG Therapeutics' options investors are not very successful. TG Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current TGTX contract

Base on the Rule 16, the options market is currently suggesting that TG Therapeutics will have an average daily up or down price movement of about 0.0606% per day over the life of the 2025-02-21 option contract. With TG Therapeutics trading at USD 29.55, that is roughly USD 0.0179. If you think that the market is fully incorporating TG Therapeutics' daily price movement you should consider buying TG Therapeutics options at the current volatility level of 0.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

TG Therapeutics Option Chain

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
TG Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on TGTX. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for TGTX. It also shows strike prices and maturity days for a TG Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
TGTX250221C00005000355.023.2 - 26.616.7In
Call
TGTX250221C0000900089.018.6 - 22.513.7In
Call
TGTX250221C0001000023210.018.2 - 21.518.65In
Call
TGTX250221C000110005911.017.2 - 20.518.0In
Call
TGTX250221C00012000312.015.6 - 19.617.05In
Call
TGTX250221C000130001013.015.2 - 18.610.6In
Call
TGTX250221C000140004014.013.6 - 17.617.7In
Call
TGTX250221C000150005115.014.4 - 15.213.53In
Call
TGTX250221C000160002016.012.5 - 13.915.8In
Call
TGTX250221C00017000117.012.4 - 13.815.7In
Call
TGTX250221C0001800010018.011.1 - 12.311.9In
Call
TGTX250221C000190002819.09.9 - 11.012.05In
Call
TGTX250221C0002000027120.09.6 - 9.99.66In
Call
TGTX250221C000210005721.08.6 - 9.18.0In
Call
TGTX250221C000220007122.06.7 - 8.27.0In
Call
TGTX250221C0002300020623.06.8 - 7.06.2In
Call
TGTX250221C0002400011624.05.9 - 6.16.1In
Call
TGTX250221C0002500037725.05.1 - 5.35.0In
Call
TGTX250221C0002600071426.04.3 - 4.54.35In
Call
TGTX250221C0002700012327.03.6 - 3.83.83In
Call
TGTX250221C0002800045228.03.0 - 3.23.1In
Call
TGTX250221C0002900017329.02.45 - 2.62.51In
Call
TGTX250221C00030000104230.01.95 - 2.151.9Out
Call
TGTX250221C0003100091231.00.95 - 1.751.63Out
Call
TGTX250221C0003200018832.01.25 - 1.41.31Out
Call
TGTX250221C0003300057633.01.0 - 1.151.05Out
Call
TGTX250221C0003400026434.00.75 - 0.950.8Out
Call
TGTX250221C00035000127735.00.6 - 0.750.65Out
Call
TGTX250221C0003600011336.00.5 - 0.650.55Out
Call
TGTX250221C00037000190337.00.4 - 0.550.45Out
Call
TGTX250221C000380007538.00.3 - 0.50.75Out
Call
TGTX250221C000390004639.00.2 - 0.40.3Out
Call
TGTX250221C0004000088440.00.2 - 0.30.25Out
Call
TGTX250221C000410001941.00.1 - 0.30.56Out
Call
TGTX250221C0004200031042.00.1 - 0.30.17Out
Call
TGTX250221C000430001143.00.05 - 0.251.15Out
Call
TGTX250221C000440004044.00.05 - 0.51.11Out
Call
TGTX250221C000450006345.00.0 - 1.70.35Out
Call
TGTX250221C000460003846.00.05 - 0.250.58Out
Call
TGTX250221C00047000247.00.0 - 0.50.85Out
Call
TGTX250221C00048000148.00.0 - 0.51.93Out
Call
TGTX250221C0004900010849.00.0 - 0.50.53Out
Call
TGTX250221C00050000177950.00.15 - 0.20.15Out
 Put
TGTX250221P00011000511.00.0 - 0.40.23Out
 Put
TGTX250221P000120001412.00.0 - 0.40.26Out
 Put
TGTX250221P0001300018113.00.0 - 0.450.45Out
 Put
TGTX250221P000140001214.00.0 - 0.450.05Out
 Put
TGTX250221P000150001215.00.0 - 0.50.23Out
 Put
TGTX250221P0001600018316.00.0 - 0.50.3Out
 Put
TGTX250221P000170004617.00.0 - 0.50.25Out
 Put
TGTX250221P000180008318.00.0 - 0.50.25Out
 Put
TGTX250221P000190005219.00.0 - 0.50.2Out
 Put
TGTX250221P00020000920.00.0 - 0.50.4Out
 Put
TGTX250221P000210002821.00.05 - 0.20.5Out
 Put
TGTX250221P0002200016822.00.0 - 0.20.18Out
 Put
TGTX250221P0002300014223.00.2 - 0.30.87Out
 Put
TGTX250221P0002400017824.00.3 - 0.450.4Out
 Put
TGTX250221P00025000130125.00.45 - 0.60.52Out
 Put
TGTX250221P000260008126.00.7 - 0.850.8Out
 Put
TGTX250221P0002700013327.00.95 - 1.11.03Out
 Put
TGTX250221P0002800013128.01.35 - 1.51.72Out
 Put
TGTX250221P0002900015229.01.8 - 2.01.94Out
 Put
TGTX250221P0003000043630.02.3 - 2.42.5In
 Put
TGTX250221P0003100015831.02.85 - 3.13.43In
 Put
TGTX250221P0003200034932.03.5 - 3.84.1In
 Put
TGTX250221P0003300041933.04.3 - 4.54.5In
 Put
TGTX250221P000340005834.05.1 - 5.35.41In
 Put
TGTX250221P000350005035.05.8 - 6.16.6In
 Put
TGTX250221P000360001236.06.7 - 7.06.46In
 Put
TGTX250221P00037000437.07.6 - 7.99.1In
 Put
TGTX250221P00038000338.08.4 - 9.17.1In
 Put
TGTX250221P000390002039.09.4 - 9.87.65In
 Put
TGTX250221P00040000140.010.3 - 10.89.0In
 Put
TGTX250221P00041000041.011.4 - 11.811.4In
 Put
TGTX250221P00042000042.012.3 - 12.812.3In
 Put
TGTX250221P00043000043.013.3 - 14.613.3In
 Put
TGTX250221P00044000044.014.4 - 15.714.4In
 Put
TGTX250221P00045000045.015.3 - 15.815.3In
 Put
TGTX250221P00046000046.016.2 - 16.816.2In
 Put
TGTX250221P00047000047.017.3 - 17.815.1In
 Put
TGTX250221P00048000048.017.1 - 18.717.1In
 Put
TGTX250221P00049000049.019.2 - 19.719.2In
 Put
TGTX250221P00050000150.020.2 - 20.721.0In

TG Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

TG Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

TGTX Total Stockholder Equity

Total Stockholder Equity

151.67 Million

At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

TG Therapeutics Corporate Executives

Elected by the shareholders, the TG Therapeutics' board of directors comprises two types of representatives: TG Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TGTX. The board's role is to monitor TG Therapeutics' management team and ensure that shareholders' interests are well served. TG Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TG Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean CPACorporate CFOProfile

Additional Tools for TGTX Stock Analysis

When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.